Processa Pharmaceuticals, Inc. General form of registration statement for all companies including face-amount certificate companies

General form of registration statement for all companies including face-amount certificate companies

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Organization and Summary of Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Subsequent Events (Details Narrative) (10-K)

v3.10.0.1

Subsequent Events (Details Narrative) (10-K) - USD ($)		1 Months Ended
Subsequent Events (Details Narrative) (10-K) - USD ($)	Oct. 04, 2017	Mar. 31, 2018	Jan. 31, 2018	Jan. 31, 2018	Mar. 19, 2018	Dec. 31, 2017	Dec. 31, 2016
Number of common stock shares outstanding		35,272,626				35,272,626	31,745,242
Loss on cyber security fraud				$ 144,200
Parent Company [Member]
Number of common stock shares outstanding		35,272,626				246,907,902
CoNCERT Pharmaceuticals, Inc [Member]
Number of common stock shares outstanding					35,272,626
Gross proceeds from equity or other financing	$ 8,000,000
Subsequent Event [Member]
Percentage of sublicense revenue earned		15.00%
Loss on cyber security fraud			$ 144,200
Subsequent Event [Member] \| Parent Company [Member]
Percentage of sublicense revenue earned		0.00%
Gross proceeds from equity or other financing		$ 8,000,000
Sublicense revenue		8,000,000
Subsequent Event [Member] \| CoNCERT Pharmaceuticals, Inc [Member]
Amount of common stock owned		$ 8,000,000
Number of common stock shares outstanding		2,090,300
Subsequent Event [Member] \| Promet Therapeutics, LLC [Member]
Common stock percentage		6.58%
Common stock issued and outstanding percentage		5.93%

- Definition

Common stock issued and outstanding percentage.

+ References

No definition available.

+ Details

Name:	PCSA_CommonStockIssuedAndOutstandingPercentage
Namespace Prefix:	PCSA_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Common stock percentage.

+ References

No definition available.

+ Details

Name:	PCSA_CommonStockPercentage
Namespace Prefix:	PCSA_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Loss on Cybersecurity Fraud.

+ References

No definition available.

+ Details

Name:	PCSA_LossOnCybersecurityFraud
Namespace Prefix:	PCSA_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Percentage of sublicense revenue earned.

+ References

No definition available.

+ Details

Name:	PCSA_PercentageOfSublicenseRevenueEarned
Namespace Prefix:	PCSA_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21463-112644

+ Details

Name:	us-gaap_CommonStockSharesOutstanding
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.

+ References

+ Details

Name:	us-gaap_CommonStockValueOutstanding
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Revenue from multiple-deliverable arrangements that include licensing fees and services revenue. Licensing revenue is consideration received from another party for the right to use, but not own, certain of the entity's intangible assets. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Licensing fees are generally, but not always, fixed as to amount and not dependent upon the revenue generated by the licensing party. An entity may receive licensing fees for licenses that also generate royalty payments to the entity. Services revenue may be derived by providing other, nonspecified, services during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(d),(e))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

+ Details

Name:	us-gaap_LicenseAndServicesRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of cash inflow (outflow) from financing activities classified as other.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3095-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3098-108585

+ Details

Name:	us-gaap_ProceedsFromPaymentsForOtherFinancingActivities
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	us-gaap_ConsolidatedEntitiesAxis=us-gaap_ParentCompanyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=PCSA_CoNCERTPharmaceuticalsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=PCSA_PrometTherapeuticsLLCMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: